1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency

Drug Use in Renal Insufficiency

151 - 165 of 220 Results
Sort Results:
Article: Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes August 2013
PL Voices: Adherence with the New Oral Anticoagulants July 2013
Article: boxed warning about stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban) in atrial fib patients July 2013
Patient Education: Why It’s Important to Take Your Blood Thinning Meds June 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
Article: kidney risks of NSAIDs April 2013
Commentary: The "Triple Whammy" April 2013
PL Voices: Managing the “Triple Whammy” Interaction April 2013
Archive: A Note from Your Pharmacist: The New Thinking About Combining Renin-Angiotensin System Blockers March 2013
PL Voices: Combining ACEIs, ARBs, or Aliskiren (Tekturna) March 2013
Article: Does it ever make sense to COMBINE an ACEI with an ARB...or aliskiren (Tekturna) with an ACEI or ARB March 2013
PL Voices: Comparing the New Oral Anticoagulants February 2013
Article: approval of Eliquis (ELL-eh-kwiss, apixaban) will intensify the marketing war among the NEW oral anticoagulants February 2013
Article: more about bleeding with Pradaxa (dabigatran) December 2012